Recovery coefficient. by Masakazu Tsujimoto (22339504)

Subjects:

SUVmax and SUVmean for each hot sphere when the Gaussian filter is changed. by Masakazu Tsujimoto (22339504)

Subjects:

Results of dose linearity. by Masakazu Tsujimoto (22339504)

Subjects:

Revisiting the sealed heating method–V158411 decreases Chk1 nuclear immunofluorescence in HT29 cells heated in a low well volume. by Andrew J. Massey (239469)

Pretreatment with SDG prevents iron induced decrease in H9c2 cell size. by Stephanie Puukila (568109)

Mean CBD concentration (%) for duration of vegetative phase (DVP) and inflorescence fraction. by Torsten Schober (20485754)

JNK inhibitor AS601245 decreased levels of Bim and CC3 proteins and reduced neuronal apoptosis and brain infarct volume in P7 rat after HI. by Deyuan Li (769599)

“…The cell apoptosis index in the AS601245-treated brain cortex was decreased by 59% compared with the DMSO-treated brain cortex (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0132998#pone.0132998.g004" target="_blank">Fig 4G</a>). …”

Calcium release from <i>S</i>. <i>mutans</i> at decreasing pHs. by Tarcísio Jorge Leitão (4811379)

Weighted demographic characteristics by tetanus serostatus result of children 6–59 months old in the EDS-RDC II. by Alvan Cheng (6733943)

The concentration-dependent decrease of intracellular D-Ser concentrations produced by incubation of PC-12 cells with the enantiomers of ketamine (Ket) and its major metabolites ex... by Nagendra S. Singh (2620399)

Whole brain volume change over 5 years using the SIENA pipeline. by Renxin Chu (5169857)

Ranking of genotypes according to the ideotype for each trait and the percentage difference (increase or decrease) in relation to cv. M-82. by Herika Paula Pessoa (13254326)

Cerebral deep gray matter volume change over 5 years with the FSL-FIRST pipeline. by Renxin Chu (5169857)

Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

TEM images of (a) amlodipine (b) hydrochlorothiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

Opioid consumption data. by Wali U. Pirzada (22278071)

“…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”

Prescription data. by Wali U. Pirzada (22278071)

“…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”

Refill rate by surgical specialty. by Wali U. Pirzada (22278071)

“…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”

Noncontinuous data on opioid use. by Wali U. Pirzada (22278071)

“…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 ^a indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)